Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma
NCT07686744
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Renal Cell Carcinoma
Advanced
Recurrent
Refractory
Interventions
DRUG:
Personalized Neoantigen Polyepitope Peptide Vaccine
Sponsor
Jian Lin